ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
133.334,45
0,24%
S&P 500
5.752,39
0,12%
US Dollar vs BRL
5,4334
-0,09%
Bitcoin
66.306,60
1,72%
Brent Oil
71,115
0,23%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) Notícias

GH

Guardant Health (GH)

Guardant Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH
DataHoraFonteTítuloCódigoCompanhia
18/09/202409:05Business WireGOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as LongNASDAQ:GHGuardant Health Inc
16/09/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
13/09/202413:08Business WireDans le cadre de l’ESMO 2024, Guardant Health présentera des données démontrant les solides performances de sa technologie d’oncologie de précision dans plusieurs types de tumeurs avancéesNASDAQ:GHGuardant Health Inc
13/09/202410:39Business WireGuardant Health wird auf der ESMO 2024 Daten vorstellen und damit die starke Leistung seiner Präzisionsonkologie-Technologie bei mehreren fortgeschrittenen Tumorarten weiter unter Beweis stellenNASDAQ:GHGuardant Health Inc
13/09/202403:00Business WireGuardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor TypesNASDAQ:GHGuardant Health Inc
10/09/202409:00Business WireGuardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in ItalyNASDAQ:GHGuardant Health Inc
27/08/202417:05Business WireGuardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:GHGuardant Health Inc
23/08/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
23/08/202417:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GHGuardant Health Inc
22/08/202418:00Business WireGuardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
08/08/202417:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
07/08/202418:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
07/08/202417:05Business WireGuardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/08/202409:05Business WireGuardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal CancerNASDAQ:GHGuardant Health Inc
01/08/202409:30Business WireGuardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal CancerNASDAQ:GHGuardant Health Inc
01/08/202409:00Business WireGuardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence StrategiesNASDAQ:GHGuardant Health Inc
30/07/202422:34Business WireガーダントヘルスのShield™血液検査が一次スクリーニング検査オプションとしてFDAより承認、メディケア診療報酬への未来を開拓し大腸がんスクリーニング検査は新しい時代へNASDAQ:GHGuardant Health Inc
30/07/202407:00IH Market NewsToyota Reports Another Global Production Decline, Delta Sues CrowdStrike, Meta Launches AI Studio for Custom ChatbotsNASDAQ:GHGuardant Health Inc
29/07/202414:37Business WireLe test sanguin Shield™ de Guardant Health est approuvé par la FDA en tant qu’option de dépistage primaire, ouvrant la voie au remboursement par Medicare et à une nouvelle ère de dépistage du cancer colorectalNASDAQ:GHGuardant Health Inc
29/07/202407:30Business WireGuardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
24/07/202417:05Business WireGuardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:GHGuardant Health Inc
23/07/202409:05Business WireGuardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class PerformanceNASDAQ:GHGuardant Health Inc
19/07/202419:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
18/07/202418:00Business WireDr. Manuel Hidalgo Medina Joins Guardant Health Board of DirectorsNASDAQ:GHGuardant Health Inc
04/06/202417:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
04/06/202409:05Business WireGuardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancerNASDAQ:GHGuardant Health Inc
03/06/202410:18Business WireGuardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trialsNASDAQ:GHGuardant Health Inc
31/05/202409:05Business WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
30/05/202409:05Business WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
23/05/202420:03Business WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH

Seu Histórico Recente

LSE
BEL1
Rcb 4.5%
NASDAQ
PMBC
Pacific Mercantile Bancorp
DGFX
DCRUSDT
Decred
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados